1. bookVolume 1 (2017): Issue s1 (October 2017)
    EBTNA Utility Gene Test on Ophthalmology
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Open Access

Genetic testing for familial exudative vitreoretinopathy

Published Online: 27 Oct 2017
Volume & Issue: Volume 1 (2017) - Issue s1 (October 2017) - EBTNA Utility Gene Test on Ophthalmology
Page range: 51 - 53
Journal Details
License
Format
Journal
eISSN
2564-615X
First Published
30 Jan 2017
Publication timeframe
4 times per year
Languages
English
Abstract

We studied the scientific literature and disease guidelines in order to summarize the clinical utility of genetic testing for familial exudative vitreoretinopathy (FEVR). There is insufficient data to determine the prevalence of FEVR. Variations in the FZD4 (OMIM gene: 604579; OMIM disease: 133780), TSPAN12 (OMIM gene: 613138; OMIM disease: 613310) and ZNF408 (OMIM gene: 616454; OMIM disease: 616468) genes have autosomal dominant inheritance, whereas variations in LRP5 (OMIM gene: 603506; OMIM disease: 601813) have autosomal dominant or recessive inheritance and variations in NDP (OMIM gene: 300658; OMIM disease: 305390) have X-linked inheritance. Clinical diagnosis is based on clinical findings, family history, ophthalmological examination, fundoscopy, slit-lamp examination and fluorescein angiography. The genetic test is useful for confirming diagnosis and for differential diagnosis, couple risk assessment and access to clinical trials.

1. Shukla D, Singh J, Sudheer G, Soman M, John RK, Ramasamy K, et al. Familial exudative vitreoretinopathy (FEVR). Clinical profile andmanagement. Indian J Ophthalmol. 2003 Dec; 51:323-8. PubMed PMID: 14750620.Search in Google Scholar

2. Miyakubo H, Hashimoto K, Miyakubo S. Retinal vascular pattern in familial exudative vitreoretinopathy. Ophthalmology. 1984 Dec;91(12):1524-30. PubMed PMID:6084219.10.1016/S0161-6420(84)34119-7Open DOISearch in Google Scholar

3. van Nouhuys CE. Signs, complications, and platelet aggregation in familial exudative vitreoretinopathy. Am J Ophthalmol. 1991 Jan 15;111(1):34-41. PubMed PMID: 1985487.10.1016/S0002-9394(14)76893-XSearch in Google Scholar

4. Ober RR, Bird AC, Hamilton AM, Sehmi K. Autosomal dominant exudative vitreoretinopathy. Br J Ophthalmol. 1980 Feb;64(2):112-20. PubMed PMID: 7362811. Pubmed Central PMCID: PMC1039360.10.1136/bjo.64.2.11210393607362811Search in Google Scholar

5. Toomes C, Downey L. Familial Exudative Vitreoretinopathy, Autosomal Dominant. In: RA Pagon, MP Adam, HH Ardinger, SE Wallace, A Amemiya, LJH Bean, et al., editors. GeneReviews(R). Seattle (WA)1993.Search in Google Scholar

6. Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015 Jan;29(1):1-14. 1.PubMed PMID: 25323851. Pubmed Central PMCID: PMC4289842.10.1038/eye.2014.70428984225323851Search in Google Scholar

7. Chen B, Gagnon M, Shahangian S, Anderson NL, Howerton DA, Boone JD. Good Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions. MMWR Recomm Rep. 2009 Jun 12; 58 (RR-6):1-37. PubMed PMID: 19521335.Search in Google Scholar

8. Stone EM, Aldave AJ, Drack AV, Maccumber MW, Sheffield VC, Traboulsi E, et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology. 2012 Nov;119(11):2408-10. PubMed PMID: 22944025. Epub 2012/09/01.10.1016/j.ophtha.2012.05.04722944025Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo